Presentation CHIP Seattle 2017 How a CHIP Operator Manages Saphenous Vein Graft (SVG) Disease Presenter: John M. Lasala August 11, 2017
Presentation Safety and Clinical Effectiveness of DES for SVG Intervention in Older Individuals Presenter: J. Matthew Brennan July 17, 2015
Presentation TCT 2012 Prospective Evaluation Of the Xience V Everolimus-Eluting Stent In Saphenous Vein Graft Atherosclerosis: the Xience V-SVG Angiographic Study. Presenter: Emmanouil S. Brilakis, Aristotelis C. Papayannis, Abdul-rahman R. Abdel-karim, Tesfaldet T. Michael, Arif Mahmood, Lorenza B. Makke, Michele Roesle, Donald Haagen, Bavana V. Rangan, Subhash Banerjee January 03, 2012